Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between pre-biologic T2-Biomaker combinations and response to biologics in patients with severe asthma
Celeste Porsbjerg, Jonathan N. Townend, Céline Bergeron, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10

Showing 10 citing articles:

Type 2 inflammation, a common denominator in chronic airway disease?
Michaela Schedel, Victoria Heimel, Christian Taube
Current Opinion in Pulmonary Medicine (2025)
Closed Access | Times Cited: 1
Pre-biologic FeNO might predict anti-IL-5/IL-5Rα response to treatment in severe asthmatics
Bruno Sposato, Marco Scalese, Gianna Camiciottoli, et al.
Journal of Asthma (2025), pp. 1-8
Closed Access
Emerging biological treatments for asthma
Daniela Pastore, Chiara Lupia, Maria D’Amato, et al.
Expert Opinion on Emerging Drugs (2025)
Closed Access
Advances in Biologic Therapies for Allergic Diseases: Current Trends, Emerging Agents, and Future Perspectives
Ewa Alska, Dariusz Łaszczych, Katarzyna Napiórkowska-Baran, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1079-1079
Open Access
German Asthma Net: Characterisation of responders to anti-IL-5 and anti-IL-5(R) therapy
Christina Bal, Slagjana Stoshikj, Andreas Renner, et al.
Pulmonology (2025) Vol. 31, Iss. 1
Open Access
Eosinophil-Driven vs. Eosinophil-Associated Severe Asthma: Practical Implications for Target Treatment
Valentina D’Aiuto, Ilaria Mormile, Francescopaolo Granata, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1729-1729
Open Access
Real-World Biologic Use Patterns in Severe Asthma, 2015–2021: The CLEAR Study
Trung N. Tran, Stephanie Chen, Benjamin Emmanuel, et al.
Pragmatic and Observational Research (2025) Vol. Volume 16, pp. 51-66
Open Access
The clinical and pathological histology efficacy of biological therapy for severe asthma with a phenotype of type 2 inflammation - systematic review
Junhui Ma, Qiang Ma, Jing Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Exploring the pathogenesis and clinical implications of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO): a narrative review
Kantapat Simmalee, Theerasuk Kawamatawong, Joana Vitte, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Precision medicine and choosing a biologic in asthma: understanding the current state of knowledge for predictors of response and clinical remission
Sadhana Balasubramanyam, Elizabeth George, Eileen Wang
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 25, Iss. 1, pp. 66-74
Closed Access
Page 1

Scroll to top